CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Vizma Life Sciences
Vizma Life Sciences logo

Vizma Life Sciences

Durham-based Vizma Life Sciences innovates in molecular imaging and chemical analysis solutions.

Durham, NC, US🇺🇸
Founded
2020
Overview
Compare
Fundraising
Employees

Vizma Life Sciences develops next-generation

molecular imaging and chemical analysis solutions.

Vizma Life Sciences - Similar Companies

Versametrics logo

Versametrics

Molecular Vista logo

Molecular Vista

molecularvista.com

Vizgen logo

Vizgen

vizgen.com

Vitra Bioscience logo

Vitra Bioscience

Bioinformatics logo

Bioinformatics

bioinfoinc.com

Viagene logo

Viagene

viagene.com

Evizia logo

Evizia

eviziadx.com

Analiza logo

Analiza

analiza.com

GMJ Technologies logo

GMJ Technologies

gmjtechs.com

CyOmics logo

CyOmics

Vizaura logo

Vizaura

vizaura.com

Moma Therapeutics logo

Moma Therapeutics

momatx.com

Quantificare logo

Quantificare

quantificare.com

Via Scientific logo

Via Scientific

viascientific.com

PhenoVista Biosciences logo

PhenoVista Biosciences

phenovista.com

Vizma Life Sciences - Quick Facts

Who are Vizma Life Sciences' competitors?

Companies similar to Vizma Life Sciences include Versametrics, Molecular Vista, Vizgen and Vitra Bioscience.

When was Vizma Life Sciences founded?

Vizma Life Sciences was founded in 2020.

Where is Vizma Life Sciences' headquarters located?

Vizma Life Sciences' headquarters is located in Durham, NC, US.

When was Vizma Life Sciences' last funding round?

Vizma Life Sciences' most recent funding round was for $75k (USD) in September 2022.

How much disclosed funding has Vizma Life Sciences raised?

As of Sep 22, 2022, Vizma Life Sciences has disclosed funding of $150k (USD). Undisclosed round amounts are excluded.

How many employees does Vizma Life Sciences have?

Vizma Life Sciences has 5 employees as of Feb 4, 2024.

Vizma Life Sciences - Classification

Ownership
  • Private
Technology
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Analysis
  • Software
Tags
  • Biotech
  • Data
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software